Biotech's five-year bull run will eventually come to an end.
Weighing options in Catamaran Corp.

Omega: A Healthy REIT to Watch Real Money Pro($)

OHI pays shareholders a substantial annual dividend of $1.96 per share.
Even after a run, some stocks still offer growth.
Unwarranted pessimism has driven the shares down.
I like living, breathing examples of growth stocks going right.
They should improve shareholder value in coming months.
Here's what we'd need to see before trying a reentry.
What that means for investors and policymakers alike.
This biotech comes with high hopes and question marks.

Columnist Conversations

The 244 area is the first major target off the 10/16 low. It's still a good idea to trail up stops as you go,...
Time to ratchet up stops if you took anything in BIDU. See the chart below. View Char...
Market is off to a rollicking start as we close the most memorable month of October with the DJIA again achiev...
Do I really need to tell you that overnight inventory is long as measured against Thursday day session close? ...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.